Stock Update: Johnson & Johnson (NYSE:JNJ) – U.S. FDA warns on newer class of type 2 diabetes drugs

[Reuters – UK Focus] – The U.S. Food and Drug Administration on Friday warned that a widely used newer class of type 2 diabetes drugs sold by AstraZeneca (NYSE: AZN – news) , . . . → Read More: Stock Update: Johnson & Johnson (NYSE:JNJ) – U.S. FDA warns on newer class of type 2 diabetes drugs Similar Articles: Market Update (NYSE:LLY): U.S. FDA warns on newer class of type 2 diabetes drugs Company Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson to Host Investor Conference Call on First-Quarter Results Market Update (NYSE:LLY): FDA approves Boehringer-Lilly drug for type-2 diabetes patients